Back

argenx SE

Below you will find information from the register publication of inside information. The information has been provided by the organisation.

  • Registration date 26 mrt 2018 - 08:18
  • Statutory name argenx SE
  • Title argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis in Europe

Related downloads

201803260000000004_argenx announces orphan drug designation for ARGX.docx

Date last update: 16 October 2018

Share information

Share on: Share this